{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T02:04:00Z","timestamp":1760234640963,"version":"build-2065373602"},"reference-count":27,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2021,6,2]],"date-time":"2021-06-02T00:00:00Z","timestamp":1622592000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibodies"],"abstract":"<jats:p>Disease-specific COVID-19 pediatric comorbidity has not been studied effectively to date. Atopy and food anaphylaxis disease states require improved characterization of SARS-CoV-2 infection risk. To provide the first such characterization, we assessed serum samples of a highly atopic, food anaphylactic, asymptomatic pediatric cohort from across the US during the height of the pandemic. From our biobank, 172 pediatric patient serum samples were characterized specific to atopic, food anaphylactic, and immunologic markers in the US at the beginning of the pandemic, from 1 February to 20 April 2020. Clinical and demographic data were further analyzed in addition to sample analysis for SARS-CoV-2 IgM and IgG ELISA. SARS-CoV-2 antibody results were positive in six patients (4%). Nearly half of the pediatric patients had a history of asthma (49%). Total IgE, total IgG, and IgG1-3 were similar in those positive and negative to SARS-CoV-2. Median total IgG4 in the SARS-CoV-2 positive group was nearly three times (p-value = 0.02) that of the negative group. Atopy controller medications did not confer additional benefit. Our data suggest that food anaphylaxis and highly atopic children are not at increased risk for SARS-CoV-2 seropositivity. This specific population appears either at equal or potentially less risk than the general population. Total and specific IgG4 may be a novel predictor of SARS-CoV-2 infection risk specific to the allergic pediatric population.<\/jats:p>","DOI":"10.3390\/antib10020022","type":"journal-article","created":{"date-parts":[[2021,6,2]],"date-time":"2021-06-02T10:38:39Z","timestamp":1622630319000},"page":"22","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Immune Response to SARS-CoV-2 in an Asymptomatic Pediatric Allergic Cohort"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6243-4312","authenticated-orcid":false,"given":"Nathan L.","family":"Marsteller","sequence":"first","affiliation":[{"name":"The Translational Pulmonary and Immunology Research Center (TPIRC), Long Beach, CA 90806, USA"},{"name":"MemorialCare Health System, Long Beach, CA 90806, USA"},{"name":"Pediatric Pulmonology Division, Miller Children\u2019s Hospital, Long Beach, CA 90806, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana J.","family":"Fregoso","sequence":"additional","affiliation":[{"name":"The Translational Pulmonary and Immunology Research Center (TPIRC), Long Beach, CA 90806, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tricia L.","family":"Morphew","sequence":"additional","affiliation":[{"name":"Morphew Consulting, LLC, Bothell, WA 98021, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inderpal S.","family":"Randhawa","sequence":"additional","affiliation":[{"name":"The Translational Pulmonary and Immunology Research Center (TPIRC), Long Beach, CA 90806, USA"},{"name":"MemorialCare Health System, Long Beach, CA 90806, USA"},{"name":"Pediatric Pulmonology Division, Miller Children\u2019s Hospital, Long Beach, CA 90806, USA"},{"name":"Irvine School of Medicine, University of California, Irvine, CA 92617, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,6,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0140-6736(20)30154-9","article-title":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: A study of a family cluster","volume":"395","author":"Chan","year":"2020","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/S0140-6736(20)30607-3","article-title":"First known person-to-person transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the USA","volume":"395","author":"Ghinai","year":"2020","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Poline, J., Gaschignard, J., Leblanc, C., Madhi, F., Foucaud, E., Nattes, E., Faye, A., Bonacorsi, S., Mariani, P., and Varon, E. (2020). Systematic SARS-CoV-2 screening at hospital admission in children:a French prospective multicenter study. Clin Infect Dis.","DOI":"10.1093\/cid\/ciaa1044"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/s41577-020-0367-5","article-title":"Understanding SARS-CoV-2-related multisystem inflammatory syndrome in children","volume":"20","author":"Rowley","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2147\/RMHP.S257180","article-title":"COVID-19 in Children: An Ample Review","volume":"13","author":"Ciuca","year":"2020","journal-title":"Risk Manag. Healthc. Policy."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e20200702","DOI":"10.1542\/peds.2020-0702","article-title":"Epidemiology of COVID-19 Among Children in China","volume":"145","author":"Dong","year":"2020","journal-title":"Pediatrics"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1001\/jama.2020.8259","article-title":"Interpreting Diagnostic Tests for SARS-CoV-2","volume":"323","author":"Sethuraman","year":"2020","journal-title":"JAMA"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e00461-20","DOI":"10.1128\/JCM.00461-20","article-title":"Evaluation of Nucleocapsid and Spike Protein-Based Enzyme-Linked Immunosorbent Assays for Detecting Antibodies against SARS-CoV-2","volume":"58","author":"Liu","year":"2020","journal-title":"J. Clin. Microbiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e02107-20","DOI":"10.1128\/JCM.02107-20","article-title":"Neutralizing antibodies correlate with protection from SARS-CoV-2 in humans during a fishery vessel outbreak with high attack rate","volume":"58","author":"Addetia","year":"2020","journal-title":"J. Clin. Microbiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.cell.2020.05.015","article-title":"Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals","volume":"181","author":"Grifoni","year":"2020","journal-title":"Cell"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"10293","DOI":"10.1038\/s41598-020-66845-6","article-title":"Robust detection of undifferentiated iPSC among differentiated cells","volume":"10","author":"Sekine","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1017\/S0950268800048019","article-title":"The time course of the immune response to experimental coronavirus infection of man","volume":"105","author":"Callow","year":"1990","journal-title":"Epidemiol. Infect."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Rantala, A., Jaakkola, J.J., and Jaakkola, M.S. (2013). Respiratory infections in adults with atopic disease and IgE antibodies to common aeroallergens. PloS ONE, 8.","DOI":"10.1371\/journal.pone.0068582"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Singanayagam, A., Joshi, P.V., Mallia, P., and Johnston, S.L. (2012). Viruses exacerbating chronic pulmonary disease: The role of immune modulation. BMC Med., 10.","DOI":"10.1186\/1741-7015-10-27"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S2213-2600(20)30167-3","article-title":"Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection?","volume":"8","author":"Halpin","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jaci.2020.04.009","article-title":"Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2","volume":"146","author":"Jackson","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2000688","DOI":"10.1183\/13993003.00688-2020","article-title":"ACE-2 expression in the small airway epithelia of smokers and COPD patients: Implications for COVID-19","volume":"55","author":"Leung","year":"2020","journal-title":"Eur. Respir. J."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jaci.2020.09.034","article-title":"Inhaled corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I interferon","volume":"147","author":"Finney","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jpeds.2020.08.037","article-title":"Pediatric SARS-CoV-2: Clinical Presentation, Infectivity, and Immune Responses","volume":"227","author":"Yonker","year":"2020","journal-title":"J. Pediatr."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1186\/s13063-020-04641-3","article-title":"Corticosteroid therapy for critically ill patients with COVID-19: A structured summary of a study protocol for a prospective meta-analysis of randomized trials","volume":"21","author":"Sterne","year":"2020","journal-title":"Trials"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/cid\/ciaa601","article-title":"Early Short Course Corticosteroids in Hospitalized Patients with COVID-19","volume":"71","author":"Fadel","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jaci.2020.04.006","article-title":"Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan","volume":"146","author":"Li","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"232960","DOI":"10.1155\/2012\/232960","article-title":"Spectrum of Disorders Associated with Elevated Serum IgG4 Levels Encountered in Clinical Practice","volume":"2012","author":"Ryu","year":"2012","journal-title":"Int. J. Rheumatol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Bianchini, R., Karagiannis, S.N., Jordakieva, G., and Jensen-Jarolim, E. (2020). The Role of IgG4 in the Fine Tuning of Tolerance in IgE-Mediated Allergy and Cancer. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21145017"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"152001","DOI":"10.1016\/j.imbio.2020.152001","article-title":"Endothelial injury and thrombotic microangiopathy in COVID-19: Treatment with the lectin-pathway inhibitor narsoplimab. Immunobiology","volume":"225","author":"Rambaldi","year":"2020","journal-title":"Immunobiology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1034\/j.1399-3038.2002.00097.x","article-title":"Severe food-induced vasculitis in two children","volume":"13","author":"Businco","year":"2002","journal-title":"Pediatr. Allergy Immunol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Ramakrishnan, S., Nicolau, D.V., Langford, B., Mahdi, M., Jeffers, H., Mwasuku, C., Krassowska, K., Fox, R., Binnian, I., and Glover, V. (2021). Inhaled budesonide in the treatment of early COVID-19 (STOIC): A phase 2, open-label, randomised controlled trial. Lancet Respir. Med.","DOI":"10.1101\/2021.02.04.21251134"}],"container-title":["Antibodies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4468\/10\/2\/22\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:10:07Z","timestamp":1760163007000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4468\/10\/2\/22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,2]]},"references-count":27,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,6]]}},"alternative-id":["antib10020022"],"URL":"https:\/\/doi.org\/10.3390\/antib10020022","relation":{},"ISSN":["2073-4468"],"issn-type":[{"type":"electronic","value":"2073-4468"}],"subject":[],"published":{"date-parts":[[2021,6,2]]}}}